GFPT1 and acute myeloid leukemia: Inhibition of HBP activity with the purported GFAT inhibitor DON (13) resulted in growth arrest, differentiation, and death of OCI-AML3 and HL60 AML cell lines in vitro and decreased growth of HL-60 cells in immunodeficient mice without major toxicity (175).